A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia
Kexing Biopharm Co., Ltd.
Kexing Biopharm Co., Ltd.
Second Xiangya Hospital of Central South University
AVEO Pharmaceuticals, Inc.
Genfleet Therapeutics (Shanghai) Inc.
Pfizer
Pfizer
University of Rochester
University of Copenhagen
National Institute of Allergy and Infectious Diseases (NIAID)
Cedars-Sinai Medical Center
The University of Texas Medical Branch, Galveston
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
UNC Lineberger Comprehensive Cancer Center